Havana, Cuba

Liliana Oliver Ríos


Average Co-Inventor Count = 16.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Liliana Oliver Ríos Revolutionizes Cancer Treatment with Her Patent

Introduction

Liliana Oliver Ríos, a pioneering inventor based in Havana, Cuba, has made significant strides in cancer treatment through her innovative research. With her passion for immunology and dedication to advancing healthcare, she has been instrumental in developing a groundbreaking pharmaceutical composition that poses a major step forward in treating cancer.

Latest Patents

Liliana holds a patent for her invention titled "Ganglioside GM3-containing nanoparticles as immunomodulators." This unique pharmaceutical composition features conjugates of membrane vesicles and the GM3 ganglioside in a high conjugation ratio to proteins. This formulation possesses distinctive characteristics such as size, surface charge, and morphology that contribute to its effectiveness as an immunomodulator. Specifically, it significantly reduces myeloid-derived suppressor cells, positively influencing lymphocyte response and improving survival rates in cancer patients. The patent also outlines methods for administering this composition and selecting suitable candidates for treatment, particularly for cancers associated with high levels of myeloid-derived suppressor cells (MDSCs).

Career Highlights

Liliana is affiliated with the Centro de Inmunología Molecular, where she continues her groundbreaking work in the field of immunotherapy. Her research not only highlights her ingenuity as an inventor but also her commitment to enhancing patient outcomes through scientific advancements.

Collaborations

Throughout her career, Liliana has collaborated with esteemed colleagues such as Circe Mesa Pardillo and Rydell Alvarez Arzola. Together, they foster innovative solutions to combat diseases and improve health strategies, contributing to the broader field of immunology and cancer research.

Conclusion

In conclusion, Liliana Oliver Ríos represents a vital force in the ongoing battle against cancer. Her invention of GM3-containing nanoparticles as immunomodulators offers hope and promise for patients facing dire health challenges. With her unwavering dedication to innovation and collaboration, she continues to pave the way for future breakthroughs in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…